Oocyte Vitrification for Fertility Preservation in Women with Benign Gynecologic Disease: French Clinical Practice Guidelines Developed by a Modified Delphi Consensus Process.
Courbiere, Blandine; Le Roux, Enora; Mathieu d'Argent, Emmanuelleet al.
2021 • In Journal of Clinical Medicine, 10 (17), p. 3810
benign gynecologic disease; consensus study; fertility preservation; modified Delphi method; oocyte vitrification; Medicine (all); General Medicine
Abstract :
[en] International guidelines are published to provide standardized information and fertility preservation (FP) care for adults and children. The purpose of the study was to conduct a modified Delphi process for generating FP guidelines for BGD. A steering committee identified 42 potential FP practices for BGD. Then 114 key stakeholders were asked to participate in a modified Delphi process via two online survey rounds and a final meeting. Consensus was reached for 28 items. Among them, stakeholders rated age-specific information concerning the risk of diminished ovarian reserve after surgery as important but rejected proposals setting various upper and lower age limits for FP. All women should be informed about the benefit/risk balance of oocyte vitrification-in particular about the likelihood of live birth according to age. FP should not be offered in rASRM stages I and II endometriosis without endometriomas. These guidelines could be useful for gynecologists to identify situations at risk of infertility and to better inform women with BGDs who might need personalized counseling for FP.
Disciplines :
Reproductive medicine (gynecology, andrology, obstetrics)
Author, co-author :
Courbiere, Blandine ; Department of Gynecology-Obstetric and Reproductive Medicine, AP-HM, Hôpital La Conception, 13005 Marseille, France ; Aix-Marseille Université, IMBE, CNRS, IRD, Avignon Université, 13005 Marseille, France
Le Roux, Enora; Unité d'Epidémiologie Clinique, Hôpital Universitaire Robert Debré, AP-HP Nord-Université de Paris, Inserm, CIC 1426, 75019 Paris, France ; ECEVE UMR 1123, Université de Paris, Inserm, 75019 Paris, France
Mathieu d'Argent, Emmanuelle; Department of Gynecology-Obstetric and Reproductive Medicine, GRC6-UPMC, Centre Expert en Endométriose (C3E), Université Pierre-et-Marie-Curie Paris 6, Hôpital Tenon, CHU de Tenon, AP-HP, 4, rue de la Chine, 75020 Paris, France
Torre, Antoine ; Department of Gynecology-Obstetric and Reproductive Medicine, CHU Rouen, 37 bd Gambetta, 76000 Rouen, France
Patrat, Catherine; Service de Biologie de la Reproduction-CECOS, APHP Centre-Université de Paris, Site Cochin, Inserm U1016, 75014 Paris, France
Poncelet, Christophe; Department of Gynecology-Obstetric, UFR SMBH Leonard de Vinci, CH René Dubos, 95000 Cergy-Pontoise, France ; Université Sorbonne Paris Nord-Paris 13, 93200 Saint-Denis, France
Montagut, Jacques; Institut Francophone de Recherche et d'Etudes Appliquées à la Reproduction, Ifreares Toulouse, 31000 Toulouse, France
Gremeau, Anne-Sophie; Department of Gynecologic Surgery and IVF, Clermont-Ferrand, University Hospital Clermont-Ferrand, 63000 Clermont-Ferrand, France
Creux, Hélène; Clinique Saint Roch, Department of Gynecology-Obstetric and Reproductive Medicine, 34000 Montpellier, France
Peigné, Maëliss; Université Sorbonne Paris Nord-Paris 13, 93200 Saint-Denis, France ; Department of Reproductive Medicine and Fertility Preservation, AP-HP Hôpital Jean Verdier, 93143 Bondy, France
Chanavaz-Lacheray, Isabella; Centre d'Endométriose, Clinique Tivoli Ducos, 33000 Bordeaux, France
Dirian, Lara; EndoFrance, Association Française de lutte contre l'Endométriose, 70190 Tresilley, France
Fritel, Xavier ; Department of Gynecology-Obstetric and Reproductive Medicine, CHU Poitiers, 86000 Poitiers, France ; Inserm CIC-P 1402, 86021 Poitiers, France
Pouly, Jean-Luc; Department of Gynecology-Obstetric, CH Moulins Yzeure, 03000 Moulins, France
Fauconnier, Arnaud; Department of Gynecology and Obstetrics, CHI Poissy-Saint-Germain-en Laye, 78300 Poissy, France ; Research Unit 7285 Risk and Safety in Clinical Medicine for Women and Perinatal Health, Paris-Saclay University, 78300 Poissy, France
Nisolle, Michelle ; Centre Hospitalier Universitaire de Liège - CHU > > Service de gynécologie-obstétrique (CHR)
Language :
English
Title :
Oocyte Vitrification for Fertility Preservation in Women with Benign Gynecologic Disease: French Clinical Practice Guidelines Developed by a Modified Delphi Consensus Process.
The CNGOF (Collège National des Gynécologues Obstétriciens Français) provided funding for the organization of the Delphi process. Neither the patients nor the experts of the PreFerBe study were remunerated for their participation.
Lantsberg, D.; Fernando, S.; Cohen, Y.; Rombauts, L. The Role of Fertility Preservation in Women with Endometriosis: A Systematic Review. J. Minim. Invasive Gynecol. 2020, 27, 362–372, doi:10.1016/j.jmig.2019.09.780.
Somigliana, E.; Vercellini, P. Fertility Preservation in Women with Endometriosis: Speculations Are Finally over, the Time for Real Data Is Initiated. Fertil. Steril. 2020, 113, 765–766, doi:10.1016/j.fertnstert.2019.12.020.
Boulkedid, R.; Abdoul, H.; Loustau, M.; Sibony, O.; Alberti, C. Using and Reporting the Delphi Method for Selecting Healthcare Quality Indicators: A Systematic Review. PLoS ONE 2011, 6, e20476, doi:10.1371/journal.pone.0020476.
Roman, H. Endometriosis Surgery and Preservation of Fertility, What Surgeons Should Know. J. Visc. Surg. 2018, 155, S31–S36, doi:10.1016/j.jviscsurg.2018.03.002.
Stoop, D. Oocyte Vitrification for Elective Fertility Preservation: Lessons for Patient Counseling. Fertil. Steril. 2016, 105, 603–604, doi:10.1016/j.fertnstert.2015.12.044.
Grynberg, M.; Sermondade, N. Fertility Preservation: Should We Reconsider the Terminology? Hum. Reprod. 2019, 34, 1855–1857, doi:10.1093/humrep/dez160.
Cobo, A.; García-Velasco, J.; Domingo, J.; Pellicer, A.; Remohí, J. Elective and Onco-Fertility Preservation: Factors Related to IVF Outcomes. Hum. Reprod. 2018, 33, 2222–2231, doi:10.1093/humrep/dey321.
Grandone, E.; Di Micco, P.P.; Villani, M.; Colaizzo, D.; Fernández-Capitán, C.; Del Toro, J.; Rosa, V.; Bura-Riviere, A.; Quere, I.; Blanco-Molina, Á.; et al. Venous Thromboembolism in Women Undergoing Assisted Reproductive Technologies: Data from the RIETE Registry. Thromb. Haemost. 2018, 118, 1962–1968, doi:10.1055/s-0038-1673402.
Doyle, J.O.; Richter, K.S.; Lim, J.; Stillman, R.J.; Graham, J.R.; Tucker, M.J. Successful Elective and Medically Indicated Oocyte Vitrification and Warming for Autologous in Vitro Fertilization, with Predicted Birth Probabilities for Fertility Preservation According to Number of Cryopreserved Oocytes and Age at Retrieval. Fertil. Steril. 2016, 105, 459–466.e2, doi:10.1016/j.fertnstert.2015.10.026.
ETIC Endometriosis Treatment Italian Club. When More Is Not Better: 10 “don’ts” in Endometriosis Management. An ETIC* Position Statement. Hum. Reprod. Open 2019, 2019, hoz009, doi:10.1093/hropen/hoz009.
Cobo, A.; Giles, J.; Paolelli, S.; Pellicer, A.; Remohí, J.; García-Velasco, J.A. Oocyte Vitrification for Fertility Preservation in Women with Endometriosis: An Observational Study. Fertil. Steril. 2020, 113, 836–844, doi:10.1016/j.fertnstert.2019.11.017.
Giudice, L.C. Clinical Practice. Endometriosis. N. Engl. J. Med. 2010, 362, 2389–2398, doi:10.1056/NEJMcP1000274.
Schleedoorn, M.J.; Velden, A.A.E.M.; Braat, D.D.M.; Peek, R.; Fleischer, K. To Freeze or Not to Freeze? An Update on Fertility Preservation In Females with Turner Syndrome. Pediatr. Endocrinol. Rev. 2019, 16, 369–382, doi:10.17458/per.vol16.2019.svb.tofreezeornot.
Petersen, K.B. Individual Fertility Assessment and Counselling in Women of Reproductive Age. Dan. Med. J. 2016, 63, 1–26.
Hurley, E.G.; Ressler, I.B.; Young, S.; Batcheller, A.; Thomas, M.A.; DiPaola, K.B.; Rios, J. Postponing Childbearing and Fertility Preservation in Young Professional Women. South. Med. J. 2018, 111, 187–191, doi:10.14423/SMJ.0000000000000789.
Dewailly, D.; Andersen, C.Y.; Balen, A.; Broekmans, F.; Dilaver, N.; Fanchin, R.; Griesinger, G.; Kelsey, T.W.; La Marca, A.; Lambalk, C.; et al. The Physiology and Clinical Utility of Anti-Mullerian Hormone in Women. Hum. Reprod. Update 2014, 20, 370–385, doi:10.1093/humupd/dmt062.
Tehrani, F.R.; Solaymani-Dodaran, M.; Tohidi, M.; Gohari, M.R.; Azizi, F. Modeling Age at Menopause Using Serum Concentration of Anti-Mullerian Hormone. J. Clin. Endocrinol. Metab. 2013, 98, 729–735, doi:10.1210/jc.2012-3176.
Dólleman, M.; Verschuren, W.M.M.; Eijkemans, M.J.C.; Broekmans, F.J.M.; van der Schouw, Y.T. Added Value of Anti- Müllerian Hormone in Prediction of Menopause: Results from a Large Prospective Cohort Study. Hum. Reprod. 2015, 30, 1974–1981, doi:10.1093/humrep/dev145.
Lockwood, G.M. Social Egg Freezing: The Prospect of Reproductive “immortality” or a Dangerous Delusion? Reprod. Biomed. Online 2011, 23, 334–340, doi:10.1016/j.rbmo.2011.05.010.
Devenutto, L.; Quintana, R.; Quintana, T. In Vitro Activation of Ovarian Cortex and Autologous Transplantation: A Novel Approach to Primary Ovarian Insufficiency and Diminished Ovarian Reserve. Hum. Reprod. Open 2020, 2020, hoaa046, doi:10.1093/hropen/hoaa046.
